-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $59

Benzinga·08/11/2026 19:28:35
Listen to the news
Citigroup analyst Yigal Nochomovitz maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $62 to $59.